All data are based on the daily closing price as of April 28, 2025
h
Hisamitsu Pharmaceutical
4530.TSE
29.76 USD
0.01
+0.03%
Overview
Last close
29.76 usd
Market cap
2.17B usd
52 week high
32.23 usd
52 week low
22.74 usd
Target price
33.8 usd
Valuation
P/E
14.4298
Forward P/E
N/A
Price/Sales
2.0456
Price/Book Value
1.1234
Enterprise Value
1.29B usd
EV/Revenue
1.1906
EV/EBITDA
5.2998
Key financials
Revenue TTM
1.09B usd
Gross Profit TTM
635.65M usd
EBITDA TTM
175.86M usd
Earnings per Share
2.06 usd
Dividend
0.6 usd
Total assets
2.24B usd
Net debt
-664.94M usd
About
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.